Almost 25% of women with early-stage ovarian cancer do not get the recommended biopsies necessary to assess if the cancer has spread to other organs.
Researchers at the University of California Davis Cancer Center and California Cancer Registry have said that almost 25% of women with early-stage ovarian cancer do not get the recommended biopsies necessary to assess if the cancer has spread to other organs.
The researchers analyzed data on 721 presumed early-stage ovarian cancer patients in New York and California before arriving at this conclusion. They said that just 72% of women had pelvic and abdominal lymph node biopsies to check if the cancer had spread.
Ovarian Cancer | Cancer in the Ovaries - Causes, Symptoms, Treatment & Prevention
Ovarian cancer affects both the ovaries and is referred to as the 'silent killer' as the symptoms go unnoticed until the disease advances.
Ovarian cancer affects both the ovaries and is referred to as the 'silent killer' as the symptoms go unnoticed until the disease advances.
The study, which was released online, is due to appear in the April print issue of the journal Gynecological Oncology.
Source-Medindia
About Cancer in Women
Cancer is one of the frequently talked about and most feared disease that falls under the genre of lifestyle diseases that have evolved, rather rapidly, in the past two decades.
Cancer is one of the frequently talked about and most feared disease that falls under the genre of lifestyle diseases that have evolved, rather rapidly, in the past two decades.
Combined Molecular-targeted and Hormonal Therapies Offer Promise in Treating Ovarian Cancer
A combination of molecular-targeted therapy and hormonal therapy may be the most promising
A combination of molecular-targeted therapy and hormonal therapy may be the most promising
